A Clinical Study of the Effect of MK-2828 on Rosuvastatin or Furosemide in Healthy People (MK-2828-005)
Clinical trial NCT07431866 · COMPLETED
Trial details
- NCT number
- NCT07431866
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-18
- Primary completion
- 2026-06-11
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.